Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Urogenital Neoplasms 1Ovarian Neoplasms 1Ovarian Diseases 1Ovarian Cysts 1Neoplasms 1Gonadal Disorders 1Genital Neoplasms, Female 1Genital Diseases, Female 1Endocrine System Diseases 1Endocrine Gland Neoplasms 1Disease 1Cysts 1Adnexal Diseases 1

Interventions

pembrolizumab 185Gemcitabine 170Paclitaxel 152Carboplatin 137Bevacizumab 128Surveys and Questionnaires 118Cisplatin 115Docetaxel 114Blood Specimen Collection 110Cyclophosphamide 109Exercise 108Nivolumab 98Fluorouracil 90Capecitabine 86Dexamethasone 81Radiotherapy 80Irinotecan 74Standard of Care 69Pemetrexed 68Oxaliplatin 68Leucovorin 64Drug Therapy 64Cetuximab 60Erlotinib Hydrochloride 56Sorafenib 53atezolizumab 52Ipilimumab 51Doxorubicin 50trametinib 47Interviews as Topic 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms × Diffusion × Clear all
NCT02836275 2020-04-14

IOTA-MRI

KU Leuven

Phase NA Unknown
250 enrolled
Gynecologic

Adnexal Diseases, Cysts, Disease, Endocrine System Diseases, Endocrine Gland Neoplasms, Genital Diseases, Female, Genital Neoplasms, Female, Gonadal Disorders, Neoplasms, Ovarian Cysts, Ovarian Diseases, Ovarian Neoplasms, Urogenital Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡